Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol drug for fat disorder may work, but risky - FDA staff
Bristol drug for fat disorder may work, but risky - FDA staff
Bristol drug for fat disorder may work, but risky - FDA staff
Submitted by
admin
on December 10, 2013 - 9:46am
Source:
Reuters
News Tags:
Bristol-Myers Squibb
FDA
metreleptin
Headline:
Bristol drug for fat disorder may work, but risky - FDA staff
Do Not Allow Advertisers to Use My Personal information
